University of Patras
Διαταραχές σεξουαλικής λειτουργικότητας σε ασθενείς που υποβάλλονται σε ακτινοθεραπεία
Abstract
dc:descriptionPurpose. Quality of life (QoL) is now regarded important not only in oncology research but in the daily clinical practice as well. QoL is composed of many parameters including sexuality. Sexuality is a complex phenomenon that incorporates biologic, psychologic, interpersonal and behavioral dimensions. Cancer diagnosis and treatments often cause physical and psychological disruptions to sexual health. The main objective of this study was to delineate the rates and clinical course of sexual function and depression in cancer patients undergoing radical radiotherapy. Patients and methods. The evaluation included the completion of patients self-reported questionnaires. Forty-eight male and 90 female RT-naive outpatients with breast cancer or pelvic tumors completed the Female Sexual Function Index (FSFI), the International Index of Erectile Function (IIEF), the EORTC-QLQ C30 and the Hamilton Depression Scale (HDS) prior to (Phase 1) at the end (Phase 2) and 12 months post-RT (Phase 3). Results. Out of the 174 patients initially assessed, 138 agreed to participate in the study. Overall the majority of patients (93.8% of males and 80% of females) experienced intense sexual dysfunction. At presentation, males reported severe erectile dysfunction (ED) that was significantly associated with age. However, only in sexual desire (SD) was the difference between baseline and Phase 3 significant. Although the incidence of severe ED in all three Phases of the study was impressive it remained stable over time. However, only in sexual desire was the difference statistically significant particularly at Phase 1 and 3 (p<0.05). For all women an improvement was observed in all parameters of the FSFI over the course of the study. FSFI total scores at Phase 3 were higher compared to Phase 1 and 2 (p<0.05). It appeared that females who underwent pelvic radiotherapy scored lower than those who underwent breast radiotherapy. As to the primary site the differences were statistically significant among females with breast cancer (p<0.05). Pts with ECOG PS=0 presented higher total FSFI scores at Phase 3 compared to those with PS 1 (p<0.05). 53% of all patients reported some kind of depressive symptomatology at Phase 1. Depression was not related to sexual function. The majority of patients reported high levels of QoL. Conclusions. Overall the current study showed that the majority of patients with cancer treated with radiotherapy experienced intense sexual dysfunction. We conclude that cancer patients undergoing radiotherapy mainly in the pelvic region experience an important degree of sexual dysfunction and depression which the Radiation-Oncologist should not ignore. Pelvic radiotherapy affected sexual function to a higher degree than breast radiotherapy. The evaluation and the confrontation of these dysfunctions should be included in the standard routine approach of cancer patients offering them holistic care.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Vomvas, Dimitrios
- Βόμβας, Δημήτριος
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/27599